Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib effectively treats Alopecia Areata.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

0.05% betamethasone dipropionate is the most effective treatment for mild alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Coudability hairs are useful markers for alopecia areata activity.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Hydroxychloroquine may help treat alopecia areata in children.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.